LSTA · Insider Trading
Lisata Therapeutics, Inc. Common Stock
Every open-market purchase and sale reported by LSTA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-13 | Mohammad Azab | Director | A | +30,456 | — |
| 2026-01-13 | Steven M Klosk | Director | A | +30,456 | — |
| 2026-01-13 | Cynthia Louise Flowers | Director | A | +30,456 | — |
| 2026-01-13 | James Nisco | SVP, Fin/Treas, Chief Actg Off | MIXED | +8,820 | −$12.17K |
| 2026-01-13 | Heidi Henson | Director | A | +30,456 | — |
| 2026-01-13 | Gregory B Brown | Director | A | +30,456 | — |
| 2026-01-13 | David J Mazzo | President & CEO | MIXED | +39,904 | −$80.96K |
| 2026-01-13 | Tariq Imam | SVP, Bus Dev, General Counsel | MIXED | +11,499 | −$6.90K |
| 2026-01-13 | Kristen K Buck | EVP, R&D and CMO | MIXED | +13,668 | −$22.32K |
| 2025-01-13 | Mohammad Azab | Director | A | +15,789 | — |
| 2025-01-13 | Steven M Klosk | Director | A | +15,789 | — |
| 2025-01-13 | David J Mazzo | President & CEO | MIXED | +50,538 | −$115.54K |
| 2025-01-13 | Kristen K Buck | EVP, R&D and CMO | MIXED | +17,122 | −$29.90K |
| 2025-01-13 | Cynthia Louise Flowers | Director | A | +15,789 | — |
| 2025-01-13 | Heidi Henson | Director | A | +15,789 | — |
| 2025-01-13 | Gregory B Brown | Director | A | +15,789 | — |
| 2025-01-13 | James Nisco | SVP, Fin/Treas, Chief Actg Off | MIXED | +10,535 | −$16.94K |
| 2024-10-02 | David J Mazzo | President & CEO | MIXED | +31,036 | +$90.94K |
| 2024-10-02 | James Nisco | SVP, Fin/Treas, Chief Actg Off | MIXED | +1,599 | +$4.69K |
| 2024-10-02 | Kristen K Buck | EVP, R&D and CMO | MIXED | +8,637 | +$25.31K |
| 2024-01-12 | David J Mazzo | Chief Executive Officer | F | −1,026 | −$3.07K |
| 2024-01-11 | Steven M Klosk | Director | A | +19,480 | — |
| 2024-01-11 | Heidi Henson | Director | A | +19,480 | — |
| 2024-01-11 | Gregory B Brown | Director | A | +19,480 | — |
| 2024-01-11 | Mohammad Azab | Director | A | +19,480 | — |
| 2024-01-11 | Cynthia Louise Flowers | Director | A | +19,480 | — |
| 2024-01-11 | David J Mazzo | Chief Executive Officer | MIXED | +70,484 | −$72.15K |
| 2024-01-11 | Kristen K Buck | EVP, R&D and CMO | MIXED | +21,120 | −$18.07K |
| 2023-09-05 | Kristen K Buck | EVP, R&D and CMO | F | −2,908 | −$6.34K |
| 2023-01-17 | David J Mazzo | Chief Executive Officer | F | −397 | −$1.45K |
| 2023-01-12 | David J Mazzo | Chief Executive Officer | F | −1,030 | −$3.30K |
| 2023-01-11 | Heidi Henson | Director | A | +20,000 | — |
| 2023-01-11 | Erkki Ruoslahti | Director | A | +20,000 | — |
| 2023-01-11 | Steven M Klosk | Director | A | +20,000 | — |
| 2023-01-11 | Cynthia Louise Flowers | Director | A | +20,000 | — |
| 2023-01-11 | Mohammad Azab | Director | A | +20,000 | — |
| 2023-01-11 | Kristen K Buck | EVP, R&D and CMO | MIXED | +15,341 | −$8.08K |
| 2023-01-11 | David J Mazzo | Chief Executive Officer | MIXED | +48,685 | −$34.62K |
| 2023-01-11 | David W. Slack | President & CBO | MIXED | +20,642 | −$10.07K |
| 2023-01-11 | Gregory B Brown | Director | A | +20,000 | — |
| 2022-09-16 | Mohammad Azab | Director | A | +19,200 | +$120.00K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| David J Mazzo | President & CEO | 319,744 | $338.93K |
| Mohammad Azab | Director | 104,925 | $111.22K |
| Steven M Klosk | Director | 95,815 | $101.56K |
| Gregory B Brown | Director | 95,659 | $101.40K |
| Kristen K Buck | EVP, R&D and CMO | 95,609 | $101.35K |
| Cynthia Louise Flowers | Director | 95,446 | $101.17K |
| Heidi Henson | Director | 85,725 | $90.87K |
| Tariq Imam | SVP, Bus Dev, General Counsel | 38,178 | $40.47K |
| James Nisco | SVP, Fin/Treas, Chief Actg Off | 32,311 | $34.25K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the LSTA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.